AJ2-30
AJ2-30 is a SLCl5A4 inhibitor. AJ2-30 inhibits endolysosomal TLR7-9-mediated mTOR activation. AJ2-30 blocks endogenous NOD signaling. AJ2-30 can be used in inflammation studies[1][2].
Product Specifications
CAS Number
2700322-79-6
UNSPSC
12352005
Target
MTOR; NOD-like Receptor (NLR) ; Oligopeptide Cotransporter
Type
Reference compound
Related Pathways
Immunology/Inflammation; Membrane Transporter/Ion Channel; PI3K/Akt/mTOR
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/aj2-30.html
Concentration
10mM
Purity
99.72
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CCN1C2=C(C=CC=C2)C3=CC(CNC4=NC5=C(N4C)C=CC=C5)=CC=C31
Molecular Formula
C23H22N4
Molecular Weight
354.45
References & Citations
[1]Daniel Lazar, et al. Small molecule inhibitors of scl15a4 with anti-inflammatory activity. Patent. WO2021174023.|[2]Chiu TY, et al. Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activity. Nat Chem Biol. 2024 Aug;20 (8) :1000-1011.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
37471151 3x 1.0 µg DNA
PPP2R2A CRISPR All-in-one AAV vector set (with saCas9)(Human)
Sign In for Pricing
View Details CV064147-01 1 Each
Canine IgE, kappa Isotype Control antibody (HyHEL-10), PerCp
Sign In for Pricing
View Details